Literature DB >> 1700026

Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides.

P S Lim1, A B Jenson, L Cowsert, Y Nakai, L Y Lim, X W Jin, J P Sundberg.   

Abstract

Monoclonal (MAbs) and polyclonal antibodies were produced against the major capsid protein of detergent-disrupted, purified bovine papillomavirus type 1 (BPV-1). The precise locations of the corresponding epitopes were identified by the reactivity of MAbs and selected polyclonal antibodies with synthetic, overlapping, hexameric peptides corresponding with 95% of the BPV-1 major capsid protein. The topography of these epitopes was determined by reactivity of antibodies with intact (conformational and nonconformational surface epitopes) and disrupted (external or internal nonconformational epitopes) BPV-1 virions. The distribution of epitopes in various papillomaviruses of 13 different species was determined by reactivity of the MAbs and polyclonal sera with productively infected, formalin-fixed papillomas, fibropapillomas, and fibromas. Epitope scanning, using MAbs and polyclonal antisera, resulted in the precise location of BPV-1 hexameric epitopes that could be correlated with their topography on the capsid and distribution in papillomatous lesions of various species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700026     DOI: 10.1093/infdis/162.6.1263

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Interactions of protein kinase CK2 subunits.

Authors:  I Korn; S Gutkind; N Srinivasan; T L Blundell; C C Allende; J E Allende
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Urinary bladder transitional cell papilloma in a shorthorn heifer.

Authors:  D L Step; R N Streeter; A W Confer; J G Kirkpatrick; J P Sundberg; C S Arnold; K E Bartels
Journal:  Can Vet J       Date:  2000-10       Impact factor: 1.008

3.  Identification of a retina-specific Otx2 enhancer element active in immature developing photoreceptors.

Authors:  Mark M Emerson; Constance L Cepko
Journal:  Dev Biol       Date:  2011-09-21       Impact factor: 3.582

4.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

6.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 7.  Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes.

Authors:  A B Jenson; M C Jenson; L Cowsert; S J Ghim; J P Sundberg
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

8.  Shaker and ether-à-go-go K+ channel subunits fail to coassemble in Xenopus oocytes.

Authors:  C Y Tang; C T Schulteis; R M Jiménez; D M Papazian
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

9.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Authors:  Ewa Krawczyk; John A Hanover; Richard Schlegel; Frank A Suprynowicz
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

10.  Immunohistochemical detection of transgene expression in the brain using small epitope tags.

Authors:  Evy Lobbestael; Veerle Reumers; Abdelilah Ibrahimi; Kirsten Paesen; Irina Thiry; Rik Gijsbers; Chris Van den Haute; Zeger Debyser; Veerle Baekelandt; Jean-Marc Taymans
Journal:  BMC Biotechnol       Date:  2010-02-18       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.